Skip to main content
Screener/Healthcare/Biotechnology

PVLA — Palvella Therapeutics, Inc.

NASDAQ
$120.30+7.04 (+6.22%)
Small CapHealthcare
$20.20
$151.18
$113.61
$121.69
EPS (TTM)$-4.17
P/E Ratio-33.97
Dividend Yield—
Market Cap$1.50B
Volume181K
Prev Close$113.26
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$0-$15.8M$-1.20——
Q4 '25$0-$12.7M$-1.08——
Q3 '25$0-$11.3M$-1.03——
Q2 '25$0-$9.5M$-0.86——
Q1 '25$0-$8.2M$-3.68——
Q4 '24$0-$4.0M$-0.88——
Q3 '24$0-$6.8M$-2.19——
Q2 '24$0-$4.2M$-3.37——
Get Your Daily Market Recap